Nautilus debuted its platform at the US HUPO meeting last month and is seeking additional participants for its ongoing early access program.
8d
Sedana Medical AB: Sedana Medical reports first patient treated in Early Access Program in the U.S.
Sedana Medical AB (publ) today reports that the first patient has been treated in the company's Early Access Program (EAP) in the U.S. The program is approved by the U.S. Food and Drug Administration ...
SEATTLE, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NAUT) (NASDAQ: NAUT; or “Nautilus”), a company pioneering single-molecule proteome analysis, today announced the launch of an ...
Sujal Patel, Co-Founder and CEO, highlighted the public unveiling of the Nautilus Voyager instrument at the US Human Proteome Organization Conference, calling it a "key highlight" and noting, "The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results